Literature DB >> 10822075

Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis.

K S Heidinger1, A Bernardo, U Taborski, G Müller-Berghaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10822075     DOI： 10.1016/s0049-3848(00)00181-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  9 in total

Review 1.  Anticoagulation in patients with thromboembolic disease.

Authors:  R C Tait
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  [Current recommendations for prevention of thromboembolic events in patients with heart valve prostheses].

Authors:  C Gohlke-Bärwolf
Journal:  Z Kardiol       Date:  2001-12

3.  Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study).

Authors:  H Völler; J Glatz; U Taborski; A Bernardo; C Dovifat; K Heidinger
Journal:  Z Kardiol       Date:  2005-03

Review 4.  Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.

Authors:  Eric Pautas; Isabelle Gouin-Thibault; Matthieu Debray; Pascale Gaussem; Virginie Siguret
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Carl J Heneghan; Josep M Garcia-Alamino; Elizabeth A Spencer; Alison M Ward; Rafael Perera; Clare Bankhead; Pablo Alonso-Coello; David Fitzmaurice; Kamal R Mahtani; Igho J Onakpoya
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

6.  Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.

Authors:  Benjamin K A Thomson; Jennifer M MacRae; Lianne Barnieh; Jianguo Zhang; Elizabeth MacKay; Megan A Manning; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2011-09-26       Impact factor: 2.388

Review 7.  Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.

Authors:  Elizabeth S Mearns; Jessica Hawthorne; Ju-Sung Song; Craig I Coleman
Journal:  BMJ Open       Date:  2014-06-20       Impact factor: 2.692

8.  Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.

Authors:  Elizabeth S Mearns; C Michael White; Christine G Kohn; Jessica Hawthorne; Ju-Sung Song; Joy Meng; Jeff R Schein; Monika K Raut; Craig I Coleman
Journal:  Thromb J       Date:  2014-06-24

Review 9.  Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.

Authors:  Petra M G Erkens; Hugo ten Cate; Harry R Büller; Martin H Prins
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.